Vera Kidney Drug Trutakna Shows Strong Results in Phase 3 Trial

The kidney drug Trutakna, developed by Vera, has shown strong results in a Phase 3 trial. The drug stabilized kidney function and reduced the risk of death and other complications in IgAN patients.